According to Renalytix's latest financial reports the company has $6.83 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-06-30 | $24.68 M | -40.29% |
2022-06-30 | $41.33 M | -44.49% |
2021-06-30 | $74.45 M | 421.57% |
2020-06-30 | $14.27 M | 55.25% |
2019-06-30 | $9.19 M | 11113.41% |
2018-06-30 | $0.08 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Anaplan
PLAN | N/A | N/A | ๐บ๐ธ USA |